Back to search
Chronic Hepaititis B
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Chronic Hepaititis B trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Chronic Hepaititis B trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is an open-label study with single- and multiple-ascending dose arms followed by a dose expansion arm. The primary objective of the study is to determine t…
This Phase 1 non-randomized, open-label, single-dose hepatic impairment study consists of 2 cohorts, conducted in 16 subjects, 8 subjects with moderate hepatic…
Achieving clinical cure, defined as hepatitis B surface antigen (HBsAg) seroclearance, represents a major research focus and an ideal therapeutic goal for chron…